Molecular BiologySignal Transduction and Targeted TherapyPeer-reviewed
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
Pedro Casado, Ana Rio‐Machín, Juho Jalmari Miettinen…·Pedro R. Cutillas
The paper identifies two distinct subgroups of KMT2A-rearranged AML using phosphoproteomics and shows different drug response profiles.
33 citationstop 2%